Factors Associated with Clinical Outcomes of Palliative Stenting for Malignant Colonic Obstruction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Self-expandable metal stents (SEMSs) can be applied to relieve colorectal obstruction secondary to incurable primary colorectal cancer or extracolonic malignancy. We aimed to identify factors associated with clinical success and the reintervention-free survival (RFS) after palliative stenting. Methods: Cases of palliative SEMS placement between 2005 and 2019 were retrieved from the institutional database and reviewed retrospectively. Logistic regression and log-rank testing followed by Cox proportional hazard analyses were performed to investigate the predictors of the clinical success of palliative stenting and factors associated with RFS, respectively. Results: A total of 593 patients underwent palliative stenting for malignant colonic obstruction (MCO). The technical and clinical success rates were 92.9% and 83.5%, respectively. Peritoneal carcinomatosis was a predictor of clinical failure (odds ratio, 0.33; 95% confidence interval [CI], 0.17 to 0.65) in the multivariate analysis. Peritoneal carcinomatosis (hazard ratio [HR], 2.48; 95% CI, 1.69 to 3.64) and stent expansion >90% on day 1 (HR, 1.62; 95% CI, 1.05 to 2.50) were associated with a shorter RFS. Neither clinical success nor RFS was associated with extracolonic malignancy. Re-obstruction, stent migration, and perforation were responsible for most reinterventions after clinically successful palliative stenting. Conclusions: In patients requiring palliative stenting for MCO, peritoneal carcinomatosis was associated with both clinical failure and short RFS. Stent expansion >90% on postprocedural day 1 was another predictor of a short RFS after clinically successful stenting. A large prospective study is warranted to establish factors associated with RFS after successful palliative stenting for MCO.
Abstract
Background/Aims: Self-expandable metal stents (SEMSs) can be applied to relieve colorectal obstruction secondary to incurable primary colorectal cancer or extracolonic malignancy. We aimed to identify factors associated with clinical success and the reintervention-free survival (RFS) after palliative stenting. Methods: Cases of palliative SEMS placement between 2005 and 2019 were retrieved from the institutional database and reviewed retrospectively. Logistic regression and log-rank testing followed by Cox proportional hazard analyses were performed to investigate the predictors of the clinical success of palliative stenting and factors associated with RFS, respectively. Results: A total of 593 patients underwent palliative stenting for malignant colonic obstruction (MCO). The technical and clinical success rates were 92.9% and 83.5%, respectively. Peritoneal carcinomatosis was a predictor of clinical failure (odds ratio, 0.33; 95% confidence interval [CI], 0.17 to 0.65) in the multivariate analysis. Peritoneal carcinomatosis (hazard ratio [HR], 2.48; 95% CI, 1.69 to 3.64) and stent expansion >90% on day 1 (HR, 1.62; 95% CI, 1.05 to 2.50) were associated with a shorter RFS. Neither clinical success nor RFS was associated with extracolonic malignancy. Re-obstruction, stent migration, and perforation were responsible for most reinterventions after clinically successful palliative stenting. Conclusions: In patients requiring palliative stenting for MCO, peritoneal carcinomatosis was associated with both clinical failure and short RFS. Stent expansion >90% on postprocedural day 1 was another predictor of a short RFS after clinically successful stenting. A large prospective study is warranted to establish factors associated with RFS after successful palliative stenting for MCO.
참고문헌 (24)
- Carne PW, "Stents or open operation for palliation of colorectal cancer : a retrospective, cohort study of perioperative outcome and longterm survival", Dis Colon Rectum, 47, pp.1455~1461 (2004)
- Faragher IG, "Long-term results of palliative stenting or surgery for incurable obstructing colon cancer", Colorectal Dis, 10, pp.668~672 (2008)
- Small AJ, "Endoscopic placement of self-expandable metal stents for malignant colonic obstruction : long-term outcomes and complication factors", Gastrointest Endosc, 71, pp.560~572 (2010)
- Sebastian S, "Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction", Am J Gastroenterol, 99, pp.2051~2057 (2004)
- Siddiqui A, "Long-term outcomes of palliative colonic stenting versus emergency surgery for acute proximal malignant colonic obstruction : a multicenter trial", Endosc Int Open, 5, pp.E232~ (2017)
- Manes G, "Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of self-expanding metal stent : analysis of results and predictors of outcomes in a large multicenter series", Arch Surg, 146, pp.1157~1162 (2011)
- Yoon JY, "Clinical outcomes and risk factors for technical and clinical failures of self-expandable metal stent insertion for malignant colorectal obstruction", Gastrointest Endosc, 74, pp.858~868 (2011)
- Park JJ, "Impact of peritoneal carcinomatosis on clinical outcomes of patients receiving self-expandable metal stents for malignant colorectal obstruction", Endoscopy, 50, pp.1163~1174 (2018)
- Zhao XD, "Palliative treatment for incurable malignant colorectal obstructions : a meta-analysis", World J Gastroenterol, 19, pp.5565~5574 (2013)
- Liang TW, "Palliative treatment of malignant colorectal obstruction caused by advanced malignancy : a self-expanding metallic stent or surgery? A system review and meta-analysis", Surg Today, 44, pp.22~33 (2014)
- Ribeiro IB, "Colonic stent versus emergency surgery as treatment of malignant colonic obstruction in the palliative setting : a systematic review and meta-analysis", Endosc Int Open, 6, pp.E558~ (2018)
- van Hooft JE, "Selfexpandable metal stents for obstructing colonic and extracolonic cancer : European Society of Gastrointestinal Endoscopy(ESGE)Clinical Guideline", Endoscopy, 46, pp.990~1053 (2014)
- Choi JH, "Covered self-expandable metal stents are more associated with complications in the management of malignant colorectal obstruction", Surg Endosc, 27, pp.3220~3227 (2013)
- Park S, "Comparison of efficacies between stents for malignant colorectal obstruction : a randomized, prospective study", Gastrointest Endosc, 72, pp.304~310 (2010)
- Zhang Y, "Comparison of efficacy between uncovered and covered selfexpanding metallic stents in malignant large bowel obstruction : a systematic review and meta-analysis", Colorectal Dis, 14, pp.e367~ (2012)
- Kim BC, "Clinical outcomes of palliative self-expanding metallic stents in patients with malignant colorectal obstruction", J Dig Dis, 13, pp.258~266 (2012)
- Im JP, "Clinical outcomes and patency of self-expanding metal stents in patients with malignant colorectal obstruction : a prospective single center study", Int J Colorectal Dis, 23, pp.789~794 (2008)
- Suh JP, "Effectiveness of stent placement for palliative treatment in malignant colorectal obstruction and predictive factors for stent occlusion", Surg Endosc, 24, pp.400~406 (2010)
- Ji Hoon Lee, "The Learning Curve for Colorectal Stent Insertion for the Treatment of Malignant Colorectal Obstruction", Gut and Liver, 6(3), pp.328~333 (2012), 거트앤리버 소화기연관학회협의회[DOI]
- Keswani RN, "Stenting for malignant colonic obstruction : a comparison of efficacy and complications in colonic versus extracolonic malignancy", Gastrointest Endosc, 69, pp.675~680 (2009)
- Kim JY, "Comparison of treatment outcomes of endoscopic stenting for colonic and extracolonic malignant obstruction", Surg Endosc, 27, pp.272~277 (2013)
- van Halsema EE, "Perforation in colorectal stenting : a meta-analysis and a search for risk factors", Gastrointest Endosc, 79, pp.970~982 (2014)
- Lee JH, "Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab", Gastrointest Endosc, 90, pp.116~124 (2019)
- Yang Z, "A systematic review and meta-analysis of randomized trials and prospective studies comparing covered and bare self-expandable metal stents for the treatment of malignant obstruction in the digestive tract", Int J Med Sci, 10, pp.825~835 (2013)